CURIS, INC. Revenue
CURIS, INC. (CRIS) reported Revenue of $0 for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Income Statement
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax · last filed 2026-08-14
- CURIS, INC. revenue from contract with customer, excluding assessed tax for the quarter ending 2026-06-30 was $0.00, a 100.00% decline year-over-year.
- CURIS, INC. revenue from contract with customer, excluding assessed tax for the quarter ending 2026-03-31 was $0.00, a 100.00% decline year-over-year.
- CURIS, INC. revenue from contract with customer, excluding assessed tax for the quarter ending 2025-12-31 was $1.14M, a 65.98% decline year-over-year.
- CURIS, INC. revenue from contract with customer, excluding assessed tax for the quarter ending 2025-09-30 was $3.18M, a 8.36% increase year-over-year.
- CURIS, INC. revenue from contract with customer, excluding assessed tax for fiscal 2025 was $9.44M, a 13.43% decline from fiscal 2024.
- CURIS, INC. revenue from contract with customer, excluding assessed tax for fiscal 2024 was $10.91M, a 8.83% increase from fiscal 2023.
- CURIS, INC. revenue from contract with customer, excluding assessed tax for fiscal 2023 was $10.02M, a 1.37% decline from fiscal 2022.
- CURIS, INC. revenue from contract with customer, excluding assessed tax for fiscal 2022 was $10.16M, a 4.57% decline from fiscal 2021.
| Period end | Revenue from Contract with Customer, Excluding Assessed Tax 3 month | Revenue from Contract with Customer, Excluding Assessed Tax 6 month | Revenue from Contract with Customer, Excluding Assessed Tax 9 month | Revenue from Contract with Customer, Excluding Assessed Tax 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.00 10-Q · filed 2026-08-14 | $0.00 10-Q · filed 2026-08-14 | $1.14M derived: sum of 3 quarters · filed 2026-08-14 | $4.31M derived: sum of 4 quarters · filed 2026-08-14 |
| 2026-03-31 | $0.00 10-Q · filed 2026-05-13 | $1.14M derived: sum of 2 quarters · filed 2026-05-13 | $4.31M derived: sum of 3 quarters · filed 2026-05-13 | $7.06M derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-12-31 | $1.14M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-24 | $4.31M derived: sum of 2 quarters · filed 2026-03-24 | $7.06M derived: sum of 3 quarters · filed 2026-08-14 | $9.44M 10-K · filed 2026-03-24 |
| 2025-09-30 | $3.18M 10-Q · filed 2025-11-06 | $5.92M derived: sum of 2 quarters · filed 2026-08-14 | $8.30M 10-Q · filed 2025-11-06 | $11.65M derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-06-30 | $2.75M 10-Q · filed 2026-08-14 | $5.13M 10-Q · filed 2026-08-14 | $8.47M derived: sum of 3 quarters · filed 2026-08-14 | $11.40M derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-03-31 | $2.38M 10-Q · filed 2026-05-13 | $5.72M derived: sum of 2 quarters · filed 2026-05-13 | $8.66M derived: sum of 3 quarters · filed 2026-05-13 | $11.20M derived: sum of 4 quarters · filed 2026-05-13 |
| 2024-12-31 | $3.35M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-24 | $6.28M derived: sum of 2 quarters · filed 2026-03-24 | $8.82M derived: sum of 3 quarters · filed 2026-03-24 | $10.91M 10-K · filed 2026-03-24 |
| 2024-09-30 | $2.93M 10-Q · filed 2025-11-06 | $5.48M derived: sum of 2 quarters · filed 2025-11-06 | $7.56M 10-Q · filed 2025-11-06 | $10.26M derived: sum of 4 quarters · filed 2025-11-06 |
| 2024-06-30 | $2.55M 10-Q · filed 2025-08-05 | $4.63M 10-Q · filed 2025-08-05 | $7.33M derived: sum of 3 quarters · filed 2025-08-05 | $10.16M derived: sum of 4 quarters · filed 2025-08-05 |
| 2024-03-31 | $2.09M 10-Q · filed 2025-05-06 | $4.78M derived: sum of 2 quarters · filed 2025-05-06 | $7.62M derived: sum of 3 quarters · filed 2025-05-06 | $9.81M derived: sum of 4 quarters · filed 2025-05-06 |
| 2023-12-31 | $2.70M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $5.53M derived: sum of 2 quarters · filed 2025-03-31 | $7.73M derived: sum of 3 quarters · filed 2025-03-31 | $10.02M 10-K · filed 2025-03-31 |
| 2023-09-30 | $2.83M 10-Q · filed 2024-11-14 | $5.03M derived: sum of 2 quarters · filed 2024-11-14 | $7.33M 10-Q · filed 2024-11-14 | $10.21M derived: sum of 4 quarters · filed 2024-11-14 |
| 2023-06-30 | $2.20M 10-Q · filed 2024-08-01 | $4.49M 10-Q · filed 2024-08-01 | $7.38M derived: sum of 3 quarters · filed 2024-08-01 | $10.21M derived: sum of 4 quarters · filed 2024-08-01 |
| 2023-03-31 | $2.30M 10-Q · filed 2024-05-07 | $5.18M derived: sum of 2 quarters · filed 2024-05-07 | $8.01M derived: sum of 3 quarters · filed 2024-05-07 | $10.40M derived: sum of 4 quarters · filed 2024-05-07 |
| 2022-12-31 | $2.89M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-08 | $5.71M derived: sum of 2 quarters · filed 2024-02-08 | $8.11M derived: sum of 3 quarters · filed 2024-02-08 | $10.16M 10-K · filed 2024-02-08 |
| 2022-09-30 | $2.83M 10-Q · filed 2023-11-02 | $5.22M derived: sum of 2 quarters · filed 2023-11-02 | $7.28M 10-Q · filed 2023-11-02 | $10.41M derived: sum of 4 quarters · filed 2023-11-02 |
| 2022-06-30 | $2.39M 10-Q · filed 2023-08-03 | $4.45M 10-Q · filed 2023-08-03 | $7.58M derived: sum of 3 quarters · filed 2023-08-03 | $10.62M derived: sum of 4 quarters · filed 2023-08-03 |
| 2022-03-31 | $2.06M 10-Q · filed 2023-05-04 | $5.19M derived: sum of 2 quarters · filed 2023-05-04 | $8.23M derived: sum of 3 quarters · filed 2023-05-04 | $10.52M derived: sum of 4 quarters · filed 2023-05-04 |
| 2021-12-31 | $3.13M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-13 | $6.17M derived: sum of 2 quarters · filed 2023-03-13 | $8.46M derived: sum of 3 quarters · filed 2023-03-13 | $10.65M 10-K · filed 2023-03-13 |
| 2021-09-30 | $3.04M 10-Q · filed 2022-11-09 | $5.33M derived: sum of 2 quarters · filed 2022-11-09 | $7.51M 10-Q · filed 2022-11-09 | $10.54M derived: sum of 4 quarters · filed 2022-11-09 |
| 2021-06-30 | $2.29M 10-Q · filed 2022-08-04 | $4.47M 10-Q · filed 2022-08-04 | $7.50M derived: sum of 3 quarters · filed 2022-08-04 | $10.24M derived: sum of 4 quarters · filed 2022-08-04 |
| 2021-03-31 | $2.19M 10-Q · filed 2022-05-05 | $5.21M derived: sum of 2 quarters · filed 2022-05-05 | $7.96M derived: sum of 3 quarters · filed 2022-05-05 | $10.31M derived: sum of 4 quarters · filed 2022-05-05 |
| 2020-12-31 | $3.02M 10-K · filed 2021-03-16 | $5.77M derived: sum of 2 quarters · filed 2021-11-09 | $8.13M derived: sum of 3 quarters · filed 2021-11-09 | $10.84M 10-K · filed 2022-02-24 |
| 2020-09-30 | $2.74M 10-Q · filed 2021-11-09 | $5.10M derived: sum of 2 quarters · filed 2021-11-09 | $7.81M 10-Q · filed 2021-11-09 | $11.10M derived: sum of 4 quarters · filed 2021-11-09 |
| 2020-06-30 | $2.36M 10-Q · filed 2021-08-03 | $5.07M 10-Q · filed 2021-08-03 | $8.36M derived: sum of 3 quarters · filed 2021-08-03 | $11.21M derived: sum of 4 quarters · filed 2021-08-03 |
| 2020-03-31 | $2.71M 10-Q · filed 2021-05-12 | $6.00M derived: sum of 2 quarters · filed 2021-05-12 | $8.85M derived: sum of 3 quarters · filed 2021-05-12 | $10.95M derived: sum of 4 quarters · filed 2021-05-12 |
| 2019-12-31 | $3.29M 10-K · filed 2021-03-16 | $6.14M derived: sum of 2 quarters · filed 2021-03-16 | $8.24M derived: sum of 3 quarters · filed 2021-03-16 | $10.00M 10-K · filed 2022-02-24 |
| 2019-09-30 | $2.86M 10-K · filed 2021-03-16 | $4.95M derived: sum of 2 quarters · filed 2021-03-16 | $6.72M 10-Q · filed 2020-11-10 | $9.47M derived: sum of 4 quarters · filed 2021-03-16 |
| 2019-06-30 | $2.09M 10-K · filed 2021-03-16 | $3.86M 10-Q · filed 2020-08-04 | $6.62M derived: sum of 3 quarters · filed 2021-03-16 | $9.46M derived: sum of 4 quarters · filed 2021-03-16 |
| 2019-03-31 | $1.77M 10-K · filed 2021-03-16 | $4.52M derived: sum of 2 quarters · filed 2021-03-16 | $7.37M derived: sum of 3 quarters · filed 2021-03-16 | $9.73M derived: sum of 4 quarters · filed 2021-03-16 |
| 2018-12-31 | $2.75M 10-K · filed 2020-03-19 | $5.60M derived: sum of 2 quarters · filed 2020-03-19 | $7.96M derived: sum of 3 quarters · filed 2020-03-19 | $10.43M 10-K · filed 2020-03-19 |
| 2018-09-30 | $2.85M 10-K · filed 2020-03-19 | $5.21M derived: sum of 2 quarters · filed 2020-03-19 | $7.67M derived: sum of 3 quarters · filed 2020-03-19 | $10.94M derived: sum of 4 quarters · filed 2020-03-19 |
| 2018-06-30 | $2.36M 10-K · filed 2020-03-19 | $4.83M derived: sum of 2 quarters · filed 2020-03-19 | $8.09M derived: sum of 3 quarters · filed 2020-03-19 | $10.53M derived: sum of 4 quarters · filed 2020-03-19 |
| 2018-03-31 | $2.47M 10-K · filed 2020-03-19 | $5.73M derived: sum of 2 quarters · filed 2020-03-19 | $8.17M derived: sum of 3 quarters · filed 2020-03-19 | $10.23M derived: sum of 4 quarters · filed 2020-03-19 |
| 2017-12-31 | $3.26M 10-K · filed 2019-03-26 | $5.71M derived: sum of 2 quarters · filed 2019-03-26 | $7.77M derived: sum of 3 quarters · filed 2019-03-26 | $9.90M 10-K · filed 2019-03-26 |
| 2017-09-30 | $2.44M 10-K · filed 2019-03-26 | $4.50M derived: sum of 2 quarters · filed 2019-03-26 | $6.64M derived: sum of 3 quarters · filed 2019-03-26 | |
| 2017-06-30 | $2.06M 10-K · filed 2019-03-26 | $4.19M derived: sum of 2 quarters · filed 2019-03-26 | ||
| 2017-03-31 | $2.13M 10-K · filed 2019-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |